RASL10A and type 2 diabetes mellitus: The findings not only contribute valuable insights into the roles of MSANTD1, RASL10A, SOX4, YTHDF3, ZNF497, and ZNF771 in T2DM but also offer new directions and potential drug targets for the treatment of the disease.